Summary
The product Anastrozole 1mg, manufactured by Unique Pharma, was independently tested to verify its authenticity and potency. The sample, identified by batch number UN66217 exp: 03/2026, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Anastrozole in four tests, yielding concentrations of 1.24 mg, 1.05 mg, 1.09 mg, and 1.11 mg, with an average concentration of 1.1225 mg, exceeding the labeled claim of 1 mg by 12.25%, indicating a variance of up to 24% above and 5% below the stated value.
The testing process commenced on 14 October 2024, with the sample received on 18 October 2024, and the analysis completed on 22 October 2024. While the results suggest that the product meets general expectations, scrutiny of reseller-submitted samples is crucial to ensure unbiased results. Resellers might provide specific batches that meet high-quality standards, potentially affecting the perceived consistency of the product across the broader market. Independent third-party testing remains key for validation and quality assurance. This report is intended for educational purposes to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: Anastrozole 1mg
- Active Ingredient: Anastrozole
- Batch Number: UN66217 exp: 03/2026
- Expiration Date: March 2026
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #50936
- Testing Ordered: 14 October 2024
- Sample Received: 18 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 1mg (as stated on the label)
- Measured Concentrations:
- 1.24 mg
- 1.05 mg
- 1.09 mg
- 1.11 mg
- Average Measured Concentration: 1.1225 mg
- Accuracy: 112.25% (12.25% above the label claim)
- Variance Range: +24% / -5%
Verification Details
- Verification URL: www.janoshik.com/tests/50936_TGHYRV8WT6EI
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This analysis confirms the accuracy of the tested product but warrants careful evaluation as it was submitted and funded by the reseller Opitropin.EU. Resellers may submit high-quality batches for testing, which might not reflect the consistency of products available in the market. Despite Janoshik Analytical’s reputation for transparency and rigorous testing protocols, further third-party verification across multiple batches is recommended to ensure consistent quality.
Conclusion
The analysis indicates that the Anastrozole 1mg product slightly exceeds its label claim, with an average measured concentration of 1.1225 mg. This suggests reliable quality control for this batch; however, the observed variance underscores the need for additional testing across various batches to ensure consistent dosing. This report aims to support educational and harm reduction efforts, enabling consumers to make informed choices.
Disclaimer
This report is provided for educational and harm reduction purposes. Reseller-submitted testing may carry inherent biases; however, it still offers valuable insights when assessed alongside independent third-party results. Consumers are encouraged to interpret this data critically and responsibly.
